Overview

Standard Medical Management in Secondary Prevention of Ischemic Stroke in China

Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purposes of the study are to analyse the cross-section data of secondary stroke prevention in China and to carry out a standard medical management including medicine and interactive education program,and to evaluate the efficacy and safety of the standard medical management in secondary stroke prevention.
Phase:
N/A
Details
Lead Sponsor:
Peking Union Medical College Hospital
Treatments:
Aspirin
Atorvastatin
Atorvastatin Calcium
Clopidogrel
Simvastatin
Ticlopidine